Natera (NTRA) Stock: Buy, Sell, or Hold?
$322.94
+3.12 (+0.98%)
▲
5d:
-11.22%
30d:
-18.19%
90d:
+4.2%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 05, 2026
0d
Protect NTRA Gains
Updated Nov 12, 12:00 AM ET
QUANTITATIVE VERDICT
HOLD
LOW Confidence (95%)
Quality Score
67/100
Position
OVERSOLD
30-Day Fair Range
$352.32 – $421.62
Position: OVERSOLD
Forward P/E & Valuation
-955.4x
Next 12M consensus est.
Wall Street Target
$410.02
+27.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$304.00 / $431.26
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: NTRA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Nov 4, 2026 at $389.27 · last confirmed Nov 9, 2026
Strength: 6.7/10
Get Alerted When NTRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: NTRA is currently trading at $322.94, which is considered oversold relative to its 30-day fair value range of $352.32 to $421.62.
Technical Outlook: Technically, NTRA is in a strong uptrend. Immediate support is located at $304.00, while resistance sits at $431.26.
Market Sentiment: NTRA scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $410.02 (+27.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NTRA is in a strong uptrend. Immediate support is located at $304.00, while resistance sits at $431.26.
Market Sentiment: NTRA scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $410.02 (+27.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$352.32 -
$421.62
Company Quality Score
67/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
Trading Range & Key Levels
30-Day Trading Range
$352.32 -
$421.62
Current vs Trading Range
OVERSOLD
Support Level
$304.00
Resistance Level
$431.26
Current Trend
Strong Uptrend
Technical data as of
Nov 12, 2026
Protect Your Profits
Holding NTRA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 27.0% below Wall St target ($410.02)
- CAUTION: Bottoming setup, but lagging the sector by 10% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-11.2%) - monitor closely
Fundamental Context
Forward P/E (Next Year Est.)
-955.44
Wall Street Target
$410.02
(+27.0%)
Revenue Growth (YoY)
34.1%
Profit Margin
-5.7%
Share NTRA Analysis
Share this live NTRA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (NTRA)
Bearish
5 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
4 msgs
24h retail stream
Last Tracked
Nov 6, 2026
Daily AI digest
AI Retail Discussion Summary:
Natera and Guardant Health extended their losses despite reporting better-than-expected third-quarter sales. The news article suggests that the blood-testing stocks had a gory day, with Natera announcing a leadership transition.
Key Retail Themes:
CEO departure
insider selling
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:04 PM ET
Data refreshes hourly during market hours. Next update: 8:04 PM
Data refreshes hourly during market hours. Next update: 8:04 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NTRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$201 | 56 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
27 analysts |
$752 | 48 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
24 analysts |
$260 | 50 HOLD |
|
IQV
IQVIA Holdings Inc |
STRONG BUY
20 analysts |
$312 | 55 HOLD |
Advanced NTRA Option Strategies
Professional options setups generated by AI based on today's NTRA price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive NTRA Research Pages
